Hangzhou Sumgen Biotech Co., Ltd.

This study tests an experimental drug called SG301, given as an injection under the skin, for people with systemic lupus erythematosus (SLE). About 120 adults whose lupus is not well controlled by standard treatments will receive either SG301 or a placebo. The main goal is to see…